John C. Martin
2013 - Gilead Sciences
In 2013, John C. Martin earned a total compensation of $15.5M as Chairman and Chief Executive Officer at Gilead Sciences, a 1% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $3,543,750 |
|---|---|
| Option Awards | $5,250,046 |
| Salary | $1,568,765 |
| Stock Awards | $5,081,801 |
| Other | $7,500 |
| Total | $15,451,862 |
Martin received $5.3M in option awards, accounting for 34% of the total pay in 2013.
Martin also received $3.5M in non-equity incentive plan, $1.6M in salary, $5.1M in stock awards and $7.5K in other compensation.
Rankings
In 2013, John C. Martin's compensation ranked 170th out of 12,286 executives tracked by ExecPay. In other words, Martin earned more than 98.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 170 out of 12,286 | 99th |
Division Manufacturing | 50 out of 4,612 | 99th |
Major group Chemicals And Allied Products | 14 out of 1,462 | 99th |
Industry group Drugs | 9 out of 1,156 | 99th |
Industry Biological Products, Except Diagnostic Substances | 1 out of 196 | 100th |
Source: SEC filing on March 28, 2016.
Martin's colleagues
We found four more compensation records of executives who worked with John C. Martin at Gilead Sciences in 2013.